DK0462531T3 - Cyklisk polypeptid med antibiotisk aktivetet, en fremgangsmåde til fremstilling deraf og en renkultur af en Coelomycetes-stamme - Google Patents

Cyklisk polypeptid med antibiotisk aktivetet, en fremgangsmåde til fremstilling deraf og en renkultur af en Coelomycetes-stamme

Info

Publication number
DK0462531T3
DK0462531T3 DK91109856.4T DK91109856T DK0462531T3 DK 0462531 T3 DK0462531 T3 DK 0462531T3 DK 91109856 T DK91109856 T DK 91109856T DK 0462531 T3 DK0462531 T3 DK 0462531T3
Authority
DK
Denmark
Prior art keywords
hydrogen
preparation
pure culture
alkoxy
chem
Prior art date
Application number
DK91109856.4T
Other languages
English (en)
Inventor
Iwamoto Toshiro
Fujie Akihiko
Nitta Kumiko
Tsurumi Yasuhisa
Shigematsu Nobuharu
Kasahara Chiyoshi
Hino Motohiro
Okuhara Masakuni
Sakane Kazuo
Kawabata Kohji
Ohki Hidenori
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909013558A external-priority patent/GB9013558D0/en
Priority claimed from GB909023666A external-priority patent/GB9023666D0/en
Priority claimed from GB919101552A external-priority patent/GB9101552D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0462531T3 publication Critical patent/DK0462531T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Stringed Musical Instruments (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK91109856.4T 1990-06-18 1991-06-15 Cyklisk polypeptid med antibiotisk aktivetet, en fremgangsmåde til fremstilling deraf og en renkultur af en Coelomycetes-stamme DK0462531T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909013558A GB9013558D0 (en) 1990-06-18 1990-06-18 New polypeptide compound and a process for preparation thereof
GB909023666A GB9023666D0 (en) 1990-10-31 1990-10-31 Polypeptide compound and a process for preparation thereof
GB919101552A GB9101552D0 (en) 1991-01-24 1991-01-24 New polypeptide compound and a process for preparation thereof

Publications (1)

Publication Number Publication Date
DK0462531T3 true DK0462531T3 (da) 1996-11-18

Family

ID=27265144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91109856.4T DK0462531T3 (da) 1990-06-18 1991-06-15 Cyklisk polypeptid med antibiotisk aktivetet, en fremgangsmåde til fremstilling deraf og en renkultur af en Coelomycetes-stamme

Country Status (20)

Country Link
US (1) US5376634A (da)
EP (2) EP0729974A1 (da)
JP (1) JP3307410B2 (da)
KR (1) KR100199535B1 (da)
CN (1) CN1040541C (da)
AT (1) ATE143671T1 (da)
AU (1) AU651347B2 (da)
CA (1) CA2044746C (da)
DE (1) DE69122432T2 (da)
DK (1) DK0462531T3 (da)
ES (1) ES2093658T3 (da)
FI (1) FI912873A7 (da)
GR (1) GR3021780T3 (da)
HU (2) HUT58108A (da)
IE (2) IE990233A1 (da)
IL (1) IL98506A (da)
NO (1) NO912347L (da)
OA (1) OA09369A (da)
PT (1) PT98023B (da)
RU (1) RU2108342C1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
IE990233A1 (en) 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
US5428009A (en) * 1990-07-16 1995-06-27 Merck & Co., Inc. Lipopeptide derivatives
USH1638H (en) * 1990-11-08 1997-03-04 Furuta; Takahisa Use of the polypeptide compound
US5385884A (en) * 1991-08-27 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
CA2161149A1 (en) * 1993-05-04 1994-11-10 James M. Balkovec Cyclohexapeptidyl aminoalkyl ethers
AU681119B2 (en) * 1993-05-17 1997-08-21 Fujisawa Pharmaceutical Co., Ltd. New polypeptide compound and a process for preparation thereof
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
WO1996011210A1 (en) * 1994-10-07 1996-04-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
WO1996022784A1 (en) * 1995-01-26 1996-08-01 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) * 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
EP1666587A1 (en) 1996-06-13 2006-06-07 Astellas Pharma Inc. Cyclic lipopeptide acylase
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
DE19728524A1 (de) * 1997-07-04 1999-01-07 Merck Patent Gmbh Cyclische Azapeptide
JP3561917B2 (ja) 1998-02-09 2004-09-08 藤沢薬品工業株式会社 新規化合物
HUP0103714A3 (en) * 1998-05-11 2003-05-28 Takeda Pharmaceutical Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity, medicaments containing them and their use
ES2233070T3 (es) 1998-08-20 2005-06-01 ELI LILLY & COMPANY Sintesis de analogos peptidicos ciclicos modificados en el anillo.
DE69933046T2 (de) 1998-12-09 2007-09-13 Eli Lilly And Co., Indianapolis Reinigung von echinocandin cyclopeptiden
KR20020003864A (ko) 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물
AU767956B2 (en) 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
WO2000051567A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
EP1582204B1 (en) 1999-03-03 2013-09-25 Eli Lilly & Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CZ2002801A3 (cs) * 1999-09-03 2002-07-17 Sankyo Company Limited Nové sloučeniny F-15078
EP1366065A1 (en) * 2001-02-26 2003-12-03 Fujisawa Pharmaceutical Co., Ltd. Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
KR20010098986A (ko) * 2001-07-27 2001-11-09 김종군 바르는 단열재(temp-coat)
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
US7459290B1 (en) 2004-03-30 2008-12-02 Iowa State University Research Foundation, Inc. Methods of using functional 30S subunits
WO2010064219A1 (en) 2008-12-04 2010-06-10 Ranbaxy Laboratories Limited Process for the preparation of a novel intermediate for caspofungin
RU2535489C1 (ru) * 2010-09-29 2014-12-10 Шанхай Техвелл Биофармасьютикал Ко., Лтд. Способ очистки циклолипопептидных соединений или их солей
US8877777B2 (en) * 2010-09-30 2014-11-04 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof
CN102533551B (zh) 2010-12-15 2013-10-09 上海天伟生物制药有限公司 一种肽类抗生素的高产菌株及其制备方法和用途
CN102618604B (zh) * 2011-01-31 2014-09-03 上海天伟生物制药有限公司 一种环脂肽化合物的制备方法
BR112013026420A2 (pt) 2011-04-20 2020-11-03 Xellia Pharmaceuticals Aps método de produção de um sal de micafungina farmaceuticamente aceitável
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN103387975A (zh) 2012-05-11 2013-11-13 上海天伟生物制药有限公司 一种固定化环脂肽酰基转移酶及其制备方法和用途
CN116987153A (zh) * 2023-07-31 2023-11-03 上海天伟生物制药有限公司 一种高纯度棘白菌素药物杂质及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
CA1159450A (en) * 1979-12-13 1983-12-27 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
CA1182812A (en) * 1979-12-13 1985-02-19 Bernard J. Abbott Process for the preparation of derivatives of cyclic peptide nuclei
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
DE3886001T2 (de) * 1987-10-07 1994-05-26 Merck & Co Inc Fungizides Fermentationsprodukt.
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
EP0450048A4 (en) * 1989-10-18 1992-12-02 City Of Hope Stable mammalian cell lines that express aromatase
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
IE990233A1 (en) 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii

Also Published As

Publication number Publication date
ES2093658T3 (es) 1997-01-01
DE69122432T2 (de) 1997-03-20
KR920000788A (ko) 1992-01-29
JP3307410B2 (ja) 2002-07-24
GR3021780T3 (en) 1997-02-28
FI912873L (fi) 1991-12-19
IE912046A1 (en) 1991-12-18
IL98506A0 (en) 1992-07-15
CA2044746C (en) 2001-08-07
RU2108342C1 (ru) 1998-04-10
KR100199535B1 (ko) 1999-06-15
OA09369A (en) 1992-09-15
CN1059729A (zh) 1992-03-25
HU912014D0 (en) 1991-12-30
HU211740A9 (en) 1995-12-28
FI912873A7 (fi) 1991-12-19
CA2044746A1 (en) 1991-12-19
ATE143671T1 (de) 1996-10-15
CN1040541C (zh) 1998-11-04
DE69122432D1 (de) 1996-11-07
AU7843591A (en) 1992-01-16
IL98506A (en) 1996-09-12
HUT58108A (en) 1992-01-28
AU651347B2 (en) 1994-07-21
IE990233A1 (en) 2000-11-15
EP0462531B1 (en) 1996-10-02
EP0462531A2 (en) 1991-12-27
JPH04352799A (ja) 1992-12-07
US5376634A (en) 1994-12-27
NO912347L (no) 1991-12-19
FI912873A0 (fi) 1991-06-14
NO912347D0 (no) 1991-06-17
PT98023B (pt) 1998-11-30
PT98023A (pt) 1992-03-31
EP0729974A1 (en) 1996-09-04
EP0462531A3 (en) 1992-11-04

Similar Documents

Publication Publication Date Title
DK0462531T3 (da) Cyklisk polypeptid med antibiotisk aktivetet, en fremgangsmåde til fremstilling deraf og en renkultur af en Coelomycetes-stamme
DE69021176D1 (de) Polypeptid und Verfahren zu dessen Herstellung.
MY121760A (en) Benzothiazin and benzoxazin derivatives;their preparation and uses
NZ504203A (en) Pleuromutilin derivatives as antimicrobials
NZ237132A (en) Preparation of substituted oxetanones from beta-hydroxy-omega-lactones; various beta-hydroxy and beta-keto-omega-lactones
NZ238181A (en) N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions
HUT68385A (en) Polypeptide and process for producing thereof
ZA896067B (en) Chemical compounds
PT82134A (en) Process for the preparation of amino acid derivatives comprising the culturing of fr-900490 producing strain belonging to the genus discosia
MY111439A (en) Thymosin alpha 1 derivatives
GB8903036D0 (en) Chemical compounds
HU198215B (en) Process for production of compositions similar in construction with antibiotics tan-749
ES8602676A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
ES8704895A1 (es) Un metodo para preparar 1-aminoalquilamino-4-ariloxipiperidinas sustituidas
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
AU7020996A (en) UCK14 compounds
UA42798C2 (uk) Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, проміжні сполуки, фармацевтична композиція на основі аналогів 15-дезоксипергуаліну
CA1261341A (en) SPIRO[BENZOFURANE-2(3H),1'-CYCLOHEPTANES]; METHOD AND INTERMEDIATE PRODUCTS FOR PREPARING THEM; THEIR USE AS MEDICINES
GR3021336T3 (en) New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof.